Welcome to Pharm-Attorney.com | Legal Rights resources for those who have suffered from dangerous drugs - 855-435-5839
Pharm Attorney.comContact Legal Help

Strattera®

Strattera®, a drug used to treat attention deficit/hyperactivity disorder (ADHD) in children, teens, and adults also causes serious liver side effects and jaundice. Strattera® may also cause suicidal thoughts in children and teens.

Strattera® is the first and only non-stimulant medication approved by the Food and Drug Administration (FDA) for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children, adolescents, and adults. Strattera® is a norepinephrine reuptake inhibitor, a class of ADHD drugs that works differently from the other ADHD medications available.

Strattera® side effects for children and adolescents include:

  • Liver dysfunction or severe liver damage such acute hepatitis
  • Jaundice (yellow skin or eyes)
  • Dark urine
  • Tenderness on the right side of the abdomen
  • Suicidal thoughts

Strattera® (atomoxetine) is produced by Eli Lilly and Company. Strattera® was approved by the FDA in late 2002 and has rapidly risen to the ranks of best seller. In 2003, 3.5 million prescriptions were prescribed for Strattera® in the United States. Retail sales exceeded $390 million. In September 2005, the FDA advised Eli Lilly to put a label include a “boxed warning” and additional warning statements that alerts health care providers about the increased risk of suicidal thinking in children and adolescents. On December 17, 2004, FDA issued a new bold label warning for Strattera® to include the potential for severe liver toxicity following reports of two patients who suffered severe liver injury. Both patients recovered. The new Strattera® warning advises of severe liver injury that may progress to liver failure, potentially resulting in death, or the need for a liver transplant in some patients. The labeling also notes that the number of actual cases of severe liver injury is unknown because of under-reporting of post-marketing adverse events. The FDA estimates that as few as 1 in 100 to 1 in 10 serious adverse drug reactions are reported to the agency. If you or a loved one has been affected by Strattera®, please contact us for a free case evaluation and consultation.

Do you have an Strattera® Case?

Name

Phone Number

E-mail Address

Drug You Were Taking: Strattera® (Change This)

When did you begin taking the drug?

When did you stop taking the drug?

What dosage of the drug were you taking?

What side effects to you suffer?

Additional Details




About BCA Video